Acasti Pharma Inc. ACST was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost nearly 4% in the past one-month time frame.
This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acasti Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider better-ranked stocks like Mallinckrodt plc MNK, Akorn, Inc. AKRX and Dr. Reddy's Laboratories Ltd. RDY. While Mallinckrodt sport a Zacks Rank #1 (Strong Buy), Akorn and Dr. Reddy's bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acasti Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider better-ranked stocks like Mallinckrodt plc MNK, Akorn, Inc. AKRX and Dr. Reddy's Laboratories Ltd. RDY. While Mallinckrodt sport a Zacks Rank #1 (Strong Buy), Akorn and Dr. Reddy's bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ACASTI PHARMA ACST: Get Free Report
MALLINCKRODT PL MNK: Free Stock Analysis Report
AKORN INC AKRX: Free Stock Analysis Report
DOCTOR REDDYS RDY: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Movers & ShakersGeneral
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
